RVMD financials
Revolution Medicines (RVMD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RVMD income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$16.56M | -$1.18B | -$1.13B | -5.95 |
| 2024 | $0.00 | $0.00 | -$689.52M | -$600.09M | -3.58 |
| 2023 | $11.58M | $11.58M | -$487.19M | -$436.37M | -3.86 |
| 2022 | $35.38M | $35.38M | -$258.28M | -$248.71M | -3.08 |
| 2021 | $29.39M | $29.39M | -$188.01M | -$187.09M | -2.47 |
| 2020 | $42.98M | $42.98M | -$110.70M | -$108.16M | -1.62 |